Dr. Reddy's Laboratories (RDY) Q1 2012 Earnings Call July 20, 2011 9:00 am ET Executives Kallam Reddy - Managing Director, Chief Operating Officer, Executive Director, Member of the Management Council, Chairman of Management Committee, Member of Shareholders Grievance Committee, Member of Investment Committee and Member of Strategy Committee Umang Vohra - Chief Financial Officer, Chief Compliance Officer, Senior Vice President and Member of the Management Council Kedar Upadhye - Director G. Prasad - Executive Vice Chairman, Chief Executive Officer, Member of Management Council, Chairman of Investment Committee, Member of Strategy Committee, Member of Shareholders Grievance Committee and Member of Management Committee Analysts Surajit Pal - Elara Securities (India) Private Limited Bino Pathiparampil - IIFL Research Sonal Gupta - UBS Investment Bank Nitin Agarwal - IDFC Securities Ltd. Ranjit Kapadia Chirag Talati Sameer Baisiwala - Morgan Stanley Prakash Agarwal - RBS Research Bhagwan Chowdhry Saion Mukherjee - Nomura Securities Co. Ltd. Girish Bakhru - HSBC Anubhav Aggarwal - Crédit Suisse AG Hitesh Mahida - Marwadi Shares Nimish Mehta Ravi Agrawal - Standard Chartered plc Abhay Shanbhag - Deutsche Bank AG Unknown Analyst - Presentation Operator Ladies and gentlemen, good day, and welcome to the Dr. Reddy's Laboratories Ltd. Q1 FY '12 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. At this time, I would like to turn the conference over to Mr. Kedar Upadhye from Dr. Reddy's. Thank you, and over to you, sir. Kedar Upadhye Thank you, Melissa. Good morning and good evening to all the participants. Welcome to Dr. Reddy’s earnings conference call for the quarter ended June 30, 2011, which is the fourth quarter of fiscal 2012. Earlier during the day, we have released our results and the same are also posted on our website. We are conducting a live webcast of this call, and the transcript shall be available on our website soon. The discussion and analysis in this call will be based on IFRS consolidated financials.
